가시오가피 열수추출물의 전신성 Anaphylaxis에 대한 억제효과

Effect of Hot Water Extract from Acanthopanax senticosus on Systemic Anaphylaxis

  • Yoon, Taek-Joon (Department of Food Science and Biotechnology, Kyonggi University) ;
  • Lee, Seok-Won (Department of Oncology, Graduate School of E-W Medical Science, KyungHee University) ;
  • Shin, Kwang-Soon (Department of Food Science and Biotechnology, Kyonggi University) ;
  • Choi, Won-Hee (Research & Development Team, GooFoo Inc) ;
  • Hwang, Soo-Hyun (Department of Food Science and Biotechnology, Kyonggi University) ;
  • Seo, Sang-Hee (Research & Development Team, GooFoo Inc) ;
  • Kim, Sung-Hoon (Department of Oncology, Graduate School of E-W Medical Science, KyungHee University) ;
  • Park, Woo-Mun (Research & Development Team, GooFoo Inc)
  • 발행 : 2002.06.01

초록

마우스에서 가시오가피 열수추출물(GF-2)의 투여는 compound 48/80에 의하여 유도되는 전신성 anaphylactic shock 및 혈중 histamine과 호산구의 생산을 GF-2 농도 의존적으로 억제하였을 뿐 아니라, 마우스 복강세포에서 LPS에 의하여 유도되는 $TNF-{\alpha}$의 생산을 유의적으로 감소시켰다. 또한, 마우스에 항원으로서 ovalbumin(OVA)와 adjuvant로서 aluminium hydroxide를 사용하여 면역 후, OVA에 대한 IgG1 및 IgE 항체의 역가를 조사한 결과, GF-2의 투여는 이들 항체의 생산을 억제하였다. 이 결과는 GF-2를 항원 특이적 혹은 비특이적인 알러지 반응에 응용할 수 있는 소재로 개발 가능성 있음을 제시하였다.

Administration of hot water extracts from Acanthopanax senticosus (GF-2) prophylactically and therapeutically inhibited the systemic anaphylactic shock induced by compound 48/80 in mouse. GF-2 significantly inhibited the production of histamine and eosinophyl in mouse serum through the injection of compound 48/80 in a dose-dependent manner. GF-2 inhibited dose dependently $TNF-{\alpha}$ production of peritoneal exudative cells activated by lipopolysaccharide. Intraperitoneal injection of GF-2 suppressed the production of IgG1 and IgE antibodies in mice immunized with a mixture of ovalbumin and aluminium hydroxide. These results suggest that GF-2 may be beneficial for the treatment of nonspecific and specific anaphylactic reactions and can be potentially applied to the treatment of allergic diseases.

키워드

참고문헌

  1. Lee, J.H., Kim, Y.H., Lim, Y.J., Jung, S.J., Jeong M.H., Yee, S.T., Ahn, A.H., Park, I.S. and Kim, J.T. The effect of Korean medical drug on lymphocyte activity in allergic contact dermatitis. Kor. J. Immunol. 20: 459-466 (1998)
  2. Jun, B.D., Kang, K.J., Vhai, O.H., Song, C.H., Lee, M.S. and Shin, S.O. A simplified experimental model for the induction of anaphylactic shock and cutaneous reaction using compound 48/80. Korean J. BRM. 2: 169-191 (1992)
  3. Okunuki, H., Teshima, R., Sakushima, J., Akiyama, H., Goda, Y, Toyoda, M. and Sawada, J.I. Induction of active systemic anaphylaxis by oral sensitization with ovalbumin in mast-cell-deficient mice. Immunol. Lett. 74: 233-237 (2000) https://doi.org/10.1016/S0165-2478(00)00264-9
  4. Kim, H.M., Moon, P.D., Chae, H.J., Kim, H.R., Chung, J.G., Kim, J.J. and Lee, E.J. The stem of sinomenium acutum inhibits mast cell-mediated anaphylactic reactions and tumor necrosis fac-tor-alpha production from rat peritoneal mast cells. J. Ethnopharmacol.70: 135-141 (2000) https://doi.org/10.1016/S0378-8741(99)00160-9
  5. Miyajima, I., Dombrowicz, D., Martin, T.R., Ravetch, J.V, Kinet, J.P. and Galli, S.J. Systemic anaphylaxis in the mouse can be mediated largely through IgGl and Fc gamma RIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgGl-dependent passive anaphylaxis. J. Clin. Invest. 99: 901-914 (1997) https://doi.org/10.1172/JCI119255
  6. Kang, K.J., Chai, O.H., Choi, M.H., Shin, I.H., Lee, M.S. and Jun, B.D. Iihibitory effect of Cortex Mori on compound 48/80-induced histamine release and cAMP level of rat peritoneal mast cells. 4: 111-122 (1994)
  7. Kajita, T. and Hugli, T.E. Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activa tion of rat peritoneal mast cells by C3ades Arg. Am. J. Pathol. 138: 1359-1369 (1991)
  8. Lee, H.K., Song, W.J., and Ha, T.U. A single or combined effects of IL-4 and other varioas cytokines on IgE production of human tonsillar mononuclear cells. Kor. J. Immunol. 17: 193-201 (1995)
  9. Brekhman, I.I. and Dardymov, I.V. New substances of plant origin which increase nonspecific resistance. Annu. Rev. Pharmacol.9: 419-430 (1969) https://doi.org/10.1146/annurev.pa.09.040169.002223
  10. Davydov, M. and Krikorian, A.D. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look. J. Ethnopharmacol. 72: 345-393 (2000) https://doi.org/10.1016/S0378-8741(00)00181-1
  11. Bae, E.A., Yook, C.S., Oh, O.J., Chang, S.Y., Nohara, T. and Kim, D.H. Metabolism of chiisanoside from Acanthopanax divaricatus var. albeofructus by human intestinal bacteria and its relation to some biological activities. Biol. Pharm. Bull. 24: 582-585 (2001) https://doi.org/10.1248/bpb.24.582
  12. Park, S.Y, Chang, S.Y., Yook, C.S. and Nohara, T. New 3,4-secolupane-type triterpene glycosides from Acanthopanax senticosus formainermis. J. Nat. Prod. 63: 1630-1633 (2000) https://doi.org/10.1021/np000277c
  13. Oh, O.J., Chang, S.Y, Yook, C.S., Yang, K.S., Park, S.Y. and Nohara T. Two 3,4-seco-lupane triterpenes from leaves of Acanthopnax divaricatus var. albeofructus. Chem. Pharm. Bull. (Tokyo). 48: 879-881 (2000) https://doi.org/10.1248/cpb.48.879
  14. Yook, C.S., Chang, S.Y, Lai, J.H., Ko, S.K., Jeong, J.H. and Nohara, T. Lupane-glycoside of Acanthopanax trifoliatus forma tristigmatis leaves. Arch. Pharm. Res. 22: 629-632 (1999) https://doi.org/10.1007/BF02975337
  15. Yi, J.M., Kim, M.S., Seo, S.W., Lee, K.N., Yook, C.S. and Kim, H.M. Acanthopanax senticosus root inhibits mast cell-dependent anaphylaxis. Clin. Chim. Acta. 312: 163-168 (2001) https://doi.org/10.1016/S0009-8981(01)00613-1
  16. Kohen, R, De Boever, J. and Kim, J.B. Recent advances in chemiluminescence-based immunoassays for steroid hormones. J. Steroid. Biochem. 27: 71-79 (1987) https://doi.org/10.1016/0022-4731(87)90296-2
  17. Shin, T.Y., Kim, S.H., Lim, J.R, Suh, E.S., Jeong, H.J., Kim, B.D., Park, E.J., Hwang, W.J., Rye, D.G., Baek, S.H., An, N.H. and Kim, H.M. Effect of Vitex rotundifolia on immediate-type allergic reaction. J. Ethnopharmacol. 72: 443-450 (2000) https://doi.org/10.1016/S0378-8741(00)00258-0
  18. Mio, M., Ikeda, A., Akagi, M. and Tasaka, K. Inhibitory effect of lysophosphatidylcholine on the histamine release from rat peritoneal mast cells. Agents Actions. 16: 113-117 (1985) https://doi.org/10.1007/BF01983115
  19. Lee, J.K., Yum, J.Y., Kim, Y.C. and Shin, T.Y. Inhibitory effect of medicinal plants on anaphylactic reaction. Yakhak Hoiji. 44: 489-493 (2000)
  20. Dahl, R., Venge, P. and Olsson, I. Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma. Studies during inhalation challenge test. Allergy. 33: 211-215 (1978) https://doi.org/10.1111/j.1398-9995.1978.tb01536.x
  21. Hogan, S.P., Mishra, A., Brandt, E.B., Foste,r P.S. and Rothenberg, M.E. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc. Natl. Acad. Sci. USA 97: 6681-6686 (2000) https://doi.org/10.1073/pnas.97.12.6681
  22. luvone, T, Den Bossche, R.V, D'Acquisto, F., Carnuccio, R. and Herman, A.G. Evidence that mast cell degranulation, histamine and tumour necrosis factor alpha release occur in LPS-induced plasma leakage in rat skin. Br. J. Pharmacol. 128: 700-704 (1999) https://doi.org/10.1038/sj.bjp.0702828
  23. Queralt, M., Brazis, R, Merlos, M., de Mora, F. and Puigdemont,A. In vitro inhibitory effect of rupatadine on histamine and TNF alpha release from dispersed canine skin mast cells and the human mast cell line HMC-l. Inflamm. Res. 49: 355-360 (2000) https://doi.org/10.1007/PL00000216
  24. Oshiba, A., Hamelmann, E., Takeda, K., Bradley, K.L., Loader, J.E., Larsen, G.L. and Gelfand, E.W. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen specific immunoglobulin (Ig) E and IgGl in mice. J. Clin. Invest97: 1398-1408 (1996)